⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGM

FULC

Fulcrum Therapeutics, Inc.

Healthcare · Biotechnology

3.68USD

+0.0000 (+0.00%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on FULC.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.

Calls on FULC

  • @VIC_BOT · Sep 3, 2026BUY

    Buy FULC at $3.65

    Imported from Value Investors Club — mack885

    +0.8%

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter-$0.11▲-$0.1810
Next quarter-$0.07▲-$0.1710
Current year-$0.66▲-$0.8211
Next year-$0.55▲-$0.6610

Recent quarters

Beat in 2 of the last 4

QuarterEstimateActualSurprise
2026-06-30-$0.22-$0.22+0.00 (+1.7%)
2026-03-31-$0.3-$0.25+0.05 (+16.8%)
2025-12-31-$0.3-$0.31-0.01 (-2.3%)
2025-09-30-$0.29-$0.31-0.02 (-5.5%)

Wall Street coverage

93 ratings from 15 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
JP MorganDowngraded from OverweightUnderweight—Jun 3, 2026
StifelDowngraded from BuyHold$25 $3Jun 2, 2026
Piper SandlerDowngraded from OverweightUnderweight$23 $3Jun 2, 2026
Truist SecuritiesDowngraded from BuyHold$17 $4Jun 2, 2026
Leerink PartnersDowngraded from OutperformMarket Perform$24 $4Jun 2, 2026
HC Wainwright & Co.Downgraded from BuyNeutral$25 $3Jun 2, 2026
JP MorganInitiatedOverweight$20Jan 12, 2026
Truist SecuritiesMaintainedBuy$14 $18Dec 11, 2025
B of A SecuritiesMaintainedUnderperform$6 $7Dec 9, 2025
RBC CapitalMaintainedSector Perform$7 $10Dec 8, 2025
Cantor FitzgeraldMaintainedOverweight$15 $24Dec 8, 2025
Piper SandlerReiteratedOverweight$16 $23Dec 8, 2025
HC Wainwright & Co.MaintainedBuy$18 $25Dec 8, 2025
Truist SecuritiesInitiatedBuy$14Nov 24, 2025
HC Wainwright & Co.MaintainedBuy$12 $18Nov 24, 2025
RBC CapitalMaintainedSector Perform$5 $7Oct 30, 2025
Piper SandlerReiteratedOverweight$12.5 $16Oct 30, 2025
HC Wainwright & Co.ReiteratedBuy$12Oct 20, 2025
RBC CapitalMaintainedSector Perform$4 $5Jul 30, 2025
HC Wainwright & Co.Upgraded from NeutralBuy$4 $12Jul 29, 2025
Piper SandlerMaintainedOverweight$6 $9May 29, 2025
Leerink PartnersUpgraded from Market PerformOutperform$4 $12May 23, 2025
Cantor FitzgeraldUpgraded from NeutralOverweight$10May 15, 2025
HC Wainwright & Co.ReiteratedNeutral$4Feb 26, 2025
RBC CapitalReiteratedSector Perform$4Nov 14, 2024

Insider transactions

10 filings from 6 insiders · 2 buy / 1 sell over 6m

Officers and directors of FULC, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
TANG KEVIN CBeneficial Owner of more than 10% of a Class of SecurityBuyindirect167.6k$3.52$595kJul 17, 2026
TANG KEVIN CBeneficial Owner of more than 10% of a Class of SecurityBuyindirect249.9k$3.54$891kJul 15, 2026
EZEKOWITZ ALANDirectorSell18.0k$3.65$66kJun 26, 2026
GOULD ROBERT J.DirectorSell15.0k$10.72$161kFeb 2, 2026
GOULD ROBERT J.DirectorSell15.0k$10.87$163kJan 2, 2026
GOULD ROBERT J.DirectorSell15.0k$11.87$178kJan 2, 2026
OLTMANS CURTIS GALEOfficerSell3.5k$12.92$45kDec 15, 2025
RA CAPITAL HEALTHCARE FUND,L.P.Beneficial Owner of more than 10% of a Class of SecuritySellindirect4.18M$13.33$58.38MDec 8, 2025
GOULD ROBERT J.DirectorSell15.0k$11.03$165kNov 19, 2025
TOURANGEAU GREGOfficerSell498$5.06$3kMay 8, 2025

Analyst Notes

Sign in to write
  • @VIC_BOT wrote a note on FULC · Sep 3, 2026Buy

    FULCRUM THERAPEUTICS INC (FULC)

    0 likes · 0 comments

Analyst Ratings

3 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current00401Hold3.40
1 mo ago00501Hold3.33
2 mo ago00502Sell3.57
Price target$3.67$3.00 – $4.00
-0.4% to target

Top voices on FULC

Members whose judged calls on FULC have played out most reliably.

No settled calls on FULC yet. 1 call is open, the first due Sep 3, 2027.

A member is listed once they have three judged calls on a name.

Sign in to make a call

A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.

A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.

A member’s prediction, judged on price history · not investment advice